Importantly, these data highlight the importance of IL-1α in atherosclerosis and the need for detailed understanding of the mechanisms of the translocation and presentation of IL-1α to the plasma membrane as a target for novel therapies, such as myristoylation inhibitors. This evidence concerns the gene IL1A and atherosclerosis.